Concord Biotech Limited

Equities

CONCORDBIO

INE338H01029

Delayed NSE India S.E. Other stock markets 03:42:53 12/02/2026 pm IST			5-day change	1st Jan Change
1,228.90 ^INR	-1.28%		+4.14%	-8.67%

11/02	Concord Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11/02	Concord Biotech Dec-quarter consol net profit 644.8 million rupees	RE

Transcript : Concord Biotech Limited, Q2 2025 Earnings Call, Nov 12, 2024

Published on 11/12/2024 at 02:00 pm IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to the Q2 FY '25 Earnings Conference Call of Concord Biotech Limited, hosted by AMBIT Capital. This

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Concord Biotech Limited

11/02	Concord Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11/02	Concord Biotech Dec-quarter consol net profit 644.8 million rupees	RE
24/12	Concord Biotech Limited Announces Resignation of Hina Patel as Company Secretary and Compliance Officer, Effective January 21, 2026	CI
18/12	Concord Biotech Names CFO	MT
18/12	Concord Biotech appoints Raviraj Karia as CFO	RE
18/12	Concord Biotech Limited Appoints Raviraj Karia as Chief Financial Officer, Effective December 18, 2025	CI
18/12	Concord Biotech Limited Appoints Raviraj Karia as Key Managerial Personnel, Effective December 18, 2025	CI
08/12	Concord Biotech says CFO Lalit Sethi to retire	RE
08/12	Concord Biotech's CFO Resigns; Shares Down 3%	MT
08/12	Concord Biotech Limited Announces Retirement of Lalit Sethi as Chief Financial Officer, Effective January 5, 2026	CI
08/12	Concord Biotech Limited Announces Retirement of Lalit Sethi as Key Managerial Personnel, Effective January 5, 2026	CI
17/11	Jefferies Adjusts Concord Biotech's Price Target to INR1,500 From INR1,600, Keeps at Hold	MT
14/11	Concord Biotech Limited, Q2 2026 Earnings Call, Nov 14, 2025
13/11	Concord Biotech posts Sept-quarter consol net profit 635.8 million rupees	RE
13/11	Concord Biotech - approves acquisition of 100% equity in Celliimune Biotech	RE
13/11	Concord Biotech Limited Approvesl to Invest Upto INR 100 Million in Captive Hybrid Solar Power Project for Limbasi Plant	CI
13/11	Concord Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
13/11	Concord Biotech Limited agreed to acquire Celliimune Biotech Private Limited.	CI
08/25/08	Indian Regulator Completes Inspection of Concord Biotech's Gujarat, India Unit	MT
30/25/30	IIFL Starts Concord Biotech at Buy With INR1,970 Price Target	MT
21/25/21	EU-GMP Authorities Conclude Inspection of Concord Biotech's Unit in Limbassi, India; Shares Up 3%	MT
21/25/21	Concord Biotech says EU-GMP conducts first inspection of API facility	RE
12/25/12	Jefferies Adjusts Concord Biotech's Price Target to INR1,600 From INR1,700, Keeps at Hold	MT
11/25/11	Concord Biotech Limited, Q1 2026 Earnings Call, Aug 11, 2025
09/25/09	Concord Biotech Limited announces Annual dividend, payable on October 09, 2025	CI